Drug-releasing sinus stent for chronic sinusitis
Part of Ear, nose & throat clinical trials.
This study tests a new sinus stent that slowly releases medication to treat chronic sinusitis. It may reduce symptoms and help avoid repeated surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with chronic sinusitis affecting both sides of your nose
- Your CT scan shows significant sinus disease
- You are not pregnant, breastfeeding, or planning to become pregnant in the next year
- You have not been in another clinical trial in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special nose dressing that slowly releases a steroid to reduce inflammation and improve healing after sinus surgery for chronic sinusitis with or without nasal polyps.
This study tests a steroid-releasing implant placed during sinus surgery to help prevent inflammation and improve healing in patients with chronic sinus infections. If you're having sinus surgery in Japan, this trial may track how well the implant works for you.
This trial tests a nasal spray called VVN432 in healthy volunteers and people with chronic sinusitis. It checks if the spray is safe and how the body processes it.
This study tests a nasal spray made from mastic oil combined with a lower dose of a standard steroid medication (mometasone) for people with chronic sinusitis. It aims to see if this combination is effective in reducing symptoms.
This trial tests whether a new form of steroid (triamcinolone) delivered in tiny capsules can improve healing after common nasal surgeries for chronic sinusitis or nasal polyps.
This trial tests a fully dissolvable stent that releases medication inside the sinuses after surgery. It is for patients with a specific type of sinusitis (eosinophilic) and nasal polyps who either need surgery or have had surgery and show early signs of inflammation returning.
Hear when a new Chronic Rhinosinusitis (CRS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.